share_log

Evercore ISI Group Initiates Coverage On Astria Therapeutics With Outperform Rating, Announces Price Target of $18

Benzinga ·  Mar 28, 2023 07:12

Evercore ISI Group analyst Liisa Bayko initiates coverage on Astria Therapeutics (NASDAQ:ATXS) with a Outperform rating and announces Price Target of $18.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment